Surrozen, Inc.
SRZN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001824893
In the last 90 days, Surrozen, Inc. insiders filed 0 open-market purchases and 1 sale; 70 institutions reported holding it in 13F filings for Q2 2026, worth $314.5M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Surrozen, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −6 vs. Q1 2022
- Shares held
- 21.1M
- −1.26M (−5.6%) vs. Q1 2022
- Total value
- $63.1M
- −$4.21M (−6.3%) vs. Q1 2022
- New holders
- 1
- 3 more added
- Sold out
- 7
- 7 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $314.5M |
| Q1 2026 | 59 | $314.2M |
| Q4 2025 | 55 | $195.1M |
| Q3 2025 | 36 | $81.7M |
| Q2 2025 | 31 | $53.9M |
| Q1 2025 | 30 | $63.5M |
| Q4 2024 | 24 | $35.4M |
| Q3 2024 | 23 | $25.5M |
| Q2 2024 | 21 | $23.1M |
| Q1 2024 | 16 | $15.0M |
| Q4 2023 | 17 | $9.78M |
| Q3 2023 | 25 | $7.90M |
| Q2 2023 | 22 | $8.62M |
| Q1 2023 | 23 | $9.91M |
| Q4 2022 | 26 | $9.36M |
| Q3 2022 | 27 | $44.1M |
| Q2 2022 | 24 | $63.1M |
| Q1 2022 | 30 | $67.4M |
| Q4 2021 | 32 | $153.5M |
| Q3 2021 | 29 | $150.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Surrozen, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| The Column Group LLC | 9,248,129 | $27.7M | 5.90% | −166,666−1.8% | Reduced |
| Consonance Capital Management LP | 3,497,500 | $10.5M | 44.25% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,500,000 | $7.50M | 0.04% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 1,200,000 | $3.53M | 0.08% | 00.0% | Unchanged |
| Harvard Management Co Inc | 826,852 | $2.43M | 0.28% | 00.0% | Unchanged |
| Euclidean Capital LLC | 802,963 | $2.41M | 2.05% | 00.0% | Unchanged |
| Bridger Management, LLC | 700,001 | $2.10M | 0.47% | 00.0% | Unchanged |
| Vanguard Group Inc | 471,979 | $1.42M | 0.00% | +1,237+0.3% | Added |
| Alyeska Investment Group, L.P. | 305,648 | $917.0K | 0.01% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 300,000 | $900.0K | 0.24% | 00.0% | Unchanged |
| Empery Asset Management, LP | 257,766 | $773.0K | 4.19% | −76,199−22.8% | Reduced |
| FMR LLC | 252,900 | $744.0K | 0.00% | +252,900 | New |
| Hudson Bay Capital Management LP | 195,400 | $574.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 172,370 | $506.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 99,128 | $298.0K | 0.00% | +62,929+173.8% | Added |
| Prelude Capital Management, LLC | 73,843 | $222.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 70,932 | $209.0K | 0.00% | 00.0% | Unchanged |
| Jasper Ridge Partners, L.P. | 46,838 | $141.0K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 35,833 | $107.0K | 0.00% | −2,155−5.7% | Reduced |
| Board of Trustees of The Leland Stanford Junior University | 24,414 | $73.0K | 0.00% | −781,960−97.0% | Reduced |
| Wolverine Asset Management LLC | 8,361 | $25.0K | 0.00% | −385−4.4% | Reduced |
| Perceptive Advisors LLC | 6,017 | $18.0K | 0.00% | −71,706−92.3% | Reduced |
| Penserra Capital Management LLC | 5,722 | $16.0K | 0.00% | −1,413−19.8% | Reduced |
| Wells Fargo & Company | 146 | $0 | 0.00% | +12+9.0% | Added |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −364,503−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −110,178−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,323−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −372−100.0% | Sold out |
| Private Capital Group, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −52−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −30−100.0% | Sold out |